Drug Safety
Drs. Jack Cush and Arthur Kavanaugh discuss highlights and key takeaways from ACR 23.
This included the following abstracts:
0025 Cannibinoids & pain
1584 TMP/SMX in GPA
0607 CAR-T cells in…
![](https://pbs.twimg.com/profile_images/1324821320429981703/dAiq_hpT_normal.jpg)
8 months 1 week ago
Large French study on infection risk of PsA biologics
12k pts over 6 years
When compared to Humira, only Enbrel and Stelara had lower infection risk
Concurrent steroid use associated with increased infection 1.85HR
@RheumNow #ACR23 Abs#2566 https://t.co/Os1esuodfl
![](https://pbs.twimg.com/media/F-8fdqzWAAAQRqN.jpg)
![](https://pbs.twimg.com/profile_images/908324013566513153/YdK61O5C_normal.jpg)
8 months 1 week ago
L16 @ #ACR23
⭐️Can you discontinue glucocorticoids (GC) & immunosuppressive agent (IM) in stable IgG4-RD (clinically quiescent for at least 12 mo)?
➡️146 pts followed for 18 mo:
👉Group 1: withdraw GC+IM
vs
👉Group 2: withdraw GC… https://t.co/j77xYm9qSN https://t.co/72IwBeEwv9
![](https://pbs.twimg.com/media/F-_GAGEW8AA9jtE.jpg)
![](https://pbs.twimg.com/profile_images/1389468430160510976/sooz0Ud3_normal.jpg)
8 months 1 week ago
Peng et al. 146 IgG4-RD in remission on immunomodulators+GC. 18 month follow-up. Withdraw IM+GC - 52% flare. Withdraw GC + continue IM 14.2% flare. Continue both 12.2% flare. Clear message that ongoing IM is the way Abstr#L16 #ACR23 #ACRbest @RheumNow https://t.co/3CAQhyTYqq https://t.co/qr1GOSvJYg
![](https://pbs.twimg.com/media/F-40wAgWsAAMNHl.jpg)
![](https://pbs.twimg.com/profile_images/1007774150000332801/SjLeJk3G_normal.jpg)
8 months 1 week ago
What happens when you stop #steroids and/ immunosuppressive Rx in Pts in remission for at least 1 yr in #IgG4 disease?
You are likely guessing correctly
Pts flare! Don’t stop Rx
?taper 🤷♀️
Like RA Rx - if stop Rx = flares
Large RCT from China L16 #ACR23 @RheumNow @RheumNow